v3.26.3
Acquisitions
 3 Months Ended
Sep. 30, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Business Combination
2. Acquisitions
Solaris Health
On November 3, 2025, we, through The Specialty Alliance, completed the acquisition of Solaris Health, a urology MSO, for a purchase price of approximately $1.9 billion in cash, subject to certain adjustments. In connection with the closing of this transaction, we issued common units in the Specialty Alliance to certain physicians and management which are estimated to have a grant date fair value of approximately $500 million, a portion of which will be recognized as post-combination expense within acquisition-related cash and share-based compensation costs.
Transaction and integration costs associated with the Solaris acquisition were $3 million during the three months ended September 30, 2026.
Fair Value of Assets Acquired and Liabilities Assumed
The allocation of the purchase price for the acquisition of Solaris Health is not yet finalized and is subject to adjustment as we complete the valuation analysis of this acquisition. The purchase price is also subject to adjustment based on working capital requirements as set forth in the acquisition agreement.
The following table summarizes the estimated fair values of the assets acquired and liabilities assumed as of the acquisition date for Solaris Health:
(in millions)Solaris Health
Identifiable intangible assets:
Trade names (1)
$233 
Non-competition agreements (2)
39 
Total identifiable intangible assets acquired
272 
Identifiable net assets/(liabilities):
Cash and equivalents
55 
Trade receivables, net
208 
Inventories23 
Prepaid expenses and other73 
Property and equipment, net62 
Other assets
193 
Accounts payable(106)
Current portion of long-term obligations and other short-term borrowings— 
Other accrued liabilities(175)
Long-term obligations, less current portion— 
Deferred income taxes and other liabilities(194)
Total identifiable net assets/(liabilities) acquired411 
Noncontrolling interest— 
Goodwill
1,726 
Total net assets acquired
$2,137